|
ABCA7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.33920000054E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.934320E-02 |
| Normal-vs-Stage2 |
2.337700E-03 |
| Normal-vs-Stage3 |
5.789700E-04 |
| Normal-vs-Stage4 |
3.017100E-04 |
| Stage1-vs-Stage2 |
1.740000E-01 |
| Stage1-vs-Stage3 |
3.670800E-01 |
| Stage1-vs-Stage4 |
7.829800E-02 |
| Stage2-vs-Stage3 |
4.946000E-01 |
| Stage2-vs-Stage4 |
7.794400E-01 |
| Stage3-vs-Stage4 |
2.802600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.014300E-04 |
| Normal-vs-AfricanAmerican |
3.13829999987192E-07 |
| Normal-vs-Asian |
2.960000E-02 |
| Caucasian-vs-AfricanAmerican |
2.760800E-03 |
| Caucasian-vs-Asian |
2.143600E-01 |
| AfricanAmerican-vs-Asian |
4.939400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.48619999999989E-05 |
| Normal-vs-Female |
1.981120E-04 |
| Male-vs-Female |
6.520600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.287650E-01 |
| Normal-vs-Age(41-60Yrs) |
3.8849000000063E-05 |
| Normal-vs-Age(61-80Yrs) |
1.144550E-03 |
| Normal-vs-Age(81-100Yrs) |
9.640200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.754400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.745200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.365200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.882000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.880000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.007400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.001800E-01 |
| Normal-vs-Grade 2 |
4.282100E-02 |
| Normal-vs-Grade 3 |
1.50746999999507E-05 |
| Normal-vs-Grade 4 |
4.49319999999975E-05 |
| Grade 1-vs-Grade 2 |
7.120800E-01 |
| Grade 1-vs-Grade 3 |
9.433400E-01 |
| Grade 1-vs-Grade 4 |
4.510000E-01 |
| Grade 2-vs-Grade 3 |
2.722400E-01 |
| Grade 2-vs-Grade 4 |
2.914300E-02 |
| Grade 3-vs-Grade 4 |
7.243900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.857600E-01 |
| Normal-vs-ccB subtype |
3.583700E-04 |
| ccA subtype-vs-ccB subtype |
3.369000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.968600E-04 |
| Normal-vs-N1 |
3.618000E-02 |
| N0-vs-N1 |
2.774800E-01 |
|
|
